Neural EGFL-like 1 (Nell-1) is a well-studied osteogenic factor that has comparable osteogenic potency with the Food and Drug Administration–approved bone morphogenic protein 2 (BMP-2). In this review, which aims to summarize the advanced Nell-1 research in the past 10 y, we start with the correlation of structural and functional relevance of the Nell-1 protein with the identification of a specific receptor of Nell-1, contactin-associated protein-like 4 (Cntnap4), for osteogenesis. The indispensable role of Nell-1 in normal craniofacial and appendicular skeletal development and growth was also defined by using the newly developed tissue-specific Nell-1 knockout mouse lines in addition to the existing transgenic mouse models. With the achievements on Nell-1’s osteogenic therapeutic evaluations from multiple preclinical animal models for local and systemic bone regeneration, the synergistic effect of Nell-1 with BMP-2 on osteogenesis, as well as the advantages of Nell-1 as an osteogenic protein with antiadipogenic, anti-inflammatory, and provascularized characteristics over BMP-2 in bone tissue engineering, is highlighted, which lays the groundwork for the clinical trial approval of Nell-1. At the molecular level, besides the mitogen-activated protein kinase (MAPK) signaling pathway, we emphasize the significant involvement of the Wnt/β-catenin pathway as well as the key regulatory molecules Runt-related transcription factor 2 (Runx2) in Nell-1-induced osteogenesis. In addition, the involvement of Nell-1 in chondrogenesis and its relevant pathologies have been revealed with the participation of the nuclear factor of activated T cells 1 (Nfatc1), Runx3, and Indian hedgehog (Ihh) signaling pathways, although the mechanistic insights of Nell-1’s osteochondrogenic property will be continuously evolving. With this perspective, we elucidate some emerging and novel functional properties of Nell-1 in oral-dental and neural tissues that will be the frontiers of future Nell-1 studies beyond the context of bone and cartilage. As such, the therapeutic potential of Nell-1 continues to evolve and grow with continuous pursuit.
AgaramNPLaquagliaMPUstunBGuoTWongGCSocciNDMakiRGDeMatteoRPBesmerPAntonescuCR. 2008. Molecular characterization of pediatric gastrointestinal stromal tumors. Clin Cancer Res. 14(10):3204–3215.
2.
AskarinamAJamesAWZaraJNGoyalRCorselliMPanALiangPChangLRackohnTStokerD, et al. 2013. Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein. Tissue Eng Part A. 19(11-12):
1386–1397.
3.
BauerYTedrowJde BernardSBirker-RobaczewskaMGibsonKFGuardelaBJHessPKlenkALindellKOPoireyS, et al. 2015. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 52(2):217–231.
4.
BokuiNOtaniTIgarashiKKakuJOdaMNagaokaTSenoMTatematsuKOkajimaTMatsuzakiT, et al. 2008. Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation. FEBS Lett. 582(2):365–371.
5.
ChenCYLiuYJShiSGChenFMCaiCLiBWangJShiLLiYLiuZY, et al. 2012. Osteogenic differentiation of human periodontal ligament stem cells expressing lentiviral nel-like protein 1. Int J Mol Med. 30(4):863–869.
6.
ChenHZhangZZhangLWangJZhangMZhuB. 2018. miR-27a protects human mitral valve interstitial cell from TNF-α-induced inflammatory injury via up-regulation of NELL-1. Braz J Med Biol Res. 51(6):e6997.
7.
ChenXYuMWangHKimJKQiHHaPJiangWChenELuoXNeedleR, et al. 2019. Cumulative inactivation of Nell-1 in wnt1 expressing cell lineages results in craniofacial skeletal hypoplasia and postnatal hydrocephalus. Cell Death Diff [epub ahead of print 3 Oct 2019] in press. doi:10.1038/s41418-019-0427-1.
8.
CowanCMZhangXJamesAWKimTMSunNWuBTingKSooC. 2012. Nell-1 increases pre-osteoblast mineralization using both phosphate transporter Pit1 and Pit2. Biochem Biophys Res Commun. 422(3):351–357.
9.
de LuisDAAlmansaRAllerRIzaolaORomeroE. 2018. Gene expression analysis identify a metabolic and cell function alterations as a hallmark of obesity without metabolic syndrome in peripheral blood, a pilot study. Clin Nutr. 37(4):1348–1353.
10.
DesaiJShannonMEJohnsonMDRuffDWHughesLAKerleyMKCarpenterDAJohnsonDKRinchikEMCuliatCT. 2006. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum Mol Genet. 15(8):1329–1341.
11.
Fahmy-GarciaSvan DrielMWitte-BuomaJWallesHvan LeeuwenJvan OschGFarrellE. 2018. NELL-1, HMGB1, and CCN2 enhance migration and vasculogenesis, but not osteogenic differentiation compared to BMP2. Tissue Eng Part A. 24(3–4):207–218.
12.
FanMJiangWXWangAYPengJZhangLXuWJLuSB. 2013. Combined effects of NEL-like type 1 gene and zoledronate in preventing collapse of the femoral head [in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 35(5):553–560.
13.
FrankeAHampeJRosenstielPBeckerCWagnerFHaslerRLittleRDHuseKRuetherABalschunT, et al. 2007. Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS One. 2(8):e691.
14.
GaoCZhangQKongDWuDSuCTongJChenFZhangQ. 2015. MALDI-TOF mass array analysis of Nell-1 promoter methylation patterns in human gastric cancer. Biomed Res Int. 2015:136941.
15.
HanQWangQWuJLiMFangYZhuHWangX. 2019. Nell-1 promotes the neural-like differentiation of dental pulp cells. Biochem Biophys Res Commun. 513(2):515–521.
16.
JamesAWLaChaudGShenJAsatrianGNguyenVZhangXTingKSooC. 2016. A review of the clinical side effects of bone morphogenetic protein-2. Tissue Eng Part B Rev. 22(4):284–297.
17.
JamesAWPanAChiangMZaraJNZhangXTingKSooC. 2011. A new function of Nell-1 protein in repressing adipogenic differentiation. Biochem Biophys Res Commun. 411(1):126–131.
18.
JamesAWShenJTsueiRNguyenAKhadarianKMeyersCAPanHCLiWKwakJHAsatrianG, et al. 2017. Nell-1 induces Sca-1+ mesenchymal progenitor cell expansion in models of bone maintenance and repair. JCI Insight. 2(12):92573.
19.
JamesAWShenJZhangXAsatrianGGoyalRKwakJHJiangLBengsBCuliatCTTurnerAS, et al. 2015. Nell-1 in the treatment of osteoporotic bone loss. Nat Commun. 6:7362.
20.
JinZMoriYYangJSatoFItoTChengYPaunBHamiltonJPKanTOlaruA, et al. 2007. Hypermethylation of the Nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Oncogene. 26(43):6332–6340.
21.
KrajaATBoreckiIBTsaiMYOrdovasJMHopkinsPNLaiCQFrazier-WoodACStrakaRJHixsonJEProvinceMA, et al. 2013. Genetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study. Lipids. 48(2):155–165.
22.
KurodaSTanizawaK. 1999. Involvement of epidermal growth factor-like domain of NELL proteins in the novel protein-protein interaction with protein kinase C. Biochem Biophys Res Commun. 265(3):752–757.
23.
KwakJZaraJNChiangMNgoRShenJJamesAWLeKMMoonCZhangXGouZ, et al. 2013. NELL-1 injection maintains long-bone quantity and quality in an ovariectomy-induced osteoporotic senile rat model. Tiss Eng Part A. 19(3–4):426–436.
24.
KwakJHZhangYParkJChenEShenJChawanCTanjayaJLeeSZhangXWuBM, et al. 2015. Pharmacokinetics and osteogenic potential of pegylated NELL-1 in vivo after systemic administration. Biomaterials. 57:73-83.
25.
LeeHSLeeJKimSOSongJSLeeJHLeeSIJungHSChoiBJ. 2013. Comparative gene-expression analysis of the dental follicle and periodontal ligament in humans. PLoS One. 8(12):e84201.
26.
LeeMSiuRKTingKWuBM. 2010. Effect of Nell-1 delivery on chondrocyte proliferation and cartilaginous extracellular matrix deposition. Tissue Eng Part A. 16(5):1791–1800.
27.
LeeSWangCPanHCShresthaSMeyersCDingCShenJChenELeeMSooC, et al. 2017. Combining smoothened agonist and Nel-like protein-1 enhances bone healing. Plast Reconstr Surg. 139(6):1385–1396.
28.
LeeSZhangXShenJJamesAWChungCGHardyRLiCGirgiusCZhangYStokerD, et al. 2015. Brief report: human perivascular stem cells and Nel-like protein-1 synergistically enhance spinal fusion in osteoporotic rats. Stem Cells. 33(10):3158–3163.
29.
LiC. 2019. Thomas M. Graber award of special merit: neural EGFL like 1 as an anti-inflammatory disease-modifying anti-arthritic drug. Paper presented at: 2019 American Association of Orthodontics Annual Session; Los Angeles, CA.
30.
LiCJiangJZhengZLeeKSZhouYChenECuliatCTQiaoYChenXTingK, et al. 2017. Neural EGFL-like 1 is a downstream regulator of Runt-related transcription factor 2 in chondrogenic differentiation and maturation. Am J Pathol. 187(5):963–972.
31.
LiCZhengZHaPChenXJiangWSunSChenFAsatrianGBerthiaumeEAKimJK, et al. 2018. Neurexin superfamily cell membrane receptor contactin-associated protein like-4 (Cntnap4) is involved in neural EGFL-like 1 (Nell-1)–responsive osteogenesis. J Bone Miner Res. 33(10):1813–1825.
32.
LiCZhengZZhangXAsatrianGChenESongRCuliatCTingKSooC. 2018. Nfatc1 is a functional transcriptional factor mediating Nell-1-induced Runx3 upregulation in chondrocytes. Int J Mol Sci. 19(1):E168.
33.
LiCSZhangXPeaultBJiangJTingKSooCZhouYH. 2016. Accelerated chondrogenic differentiation of human perivascular stem cells with Nell-1. Tissue Eng Part A. 22(3–4):272–285.
34.
LiWZaraJNSiuRKLeeMAghalooTZhangXWuBMGertzmanAATingKSooC. 2011. Nell-1 enhances bone regeneration in a rat critical-sized femoral segmental defect model. Plast Reconstr Surg. 127(2):580–587.
35.
LinEKuoPHLiuYLYuYWYangACTsaiSJ. 2018. A deep learning approach for predicting antidepressant response in major depression using clinical and genetic biomarkers. Front Psychiatry. 9:290.
36.
MathieuFEtainBDizierMHLajnefMLathropMCabonCLeboyerMHenryCBellivierF. 2015. Genetics of emotional reactivity in bipolar disorders. J Affect Disord. 188:101–106.
37.
MeyersCASunZChangLDingCLuATingKPangSJamesAW. 2019. Age dependent effects of NELL-1 isoforms on bone marrow stromal cells. J Orthopaedics. 16(2):175–178.
38.
NakamuraROyamaTTajiriRMizokamiANamikiMNakamotoMOoiA. 2015. Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma. Cancer Sci. 106(5):656–664.
39.
NakamuraYHasebeATakahashiKIijimaMYoshimotoNMaturanaADTingKKurodaSNiimiT. 2014. Oligomerization-induced conformational change in the C-terminal region of Nel-like molecule 1 (NELL1) protein is necessary for the efficient mediation of murine MC3T3-E1 cell adhesion and spreading. J Biol Chem. 289(14):9781–9794.
40.
PakvasaMAlverdyAMostafaSWangEFuLLiAOliveiraLAthivirahamALeeMJWolfJM, et al. 2017. Neural EGF-like protein 1 (NELL-1): signaling crosstalk in mesenchymal stem cells and applications in regenerative medicine. Genes Dis. 4(3):127–137.
41.
PoloYLBJSzczypiorskaMBartolomeNCamposJFlores-RoblesBJSanzJFernandez-EsparteroCClavagueraTAndrusRFArtiedaM, et al. 2019. Clinical and genetic characteristics of ankylosing spondylitis patients with peripheral arthritis at disease onset. Clin Exp Rheumatol. 37(2):215–221.
42.
QiHKimJKHaPChenXChenEChenYLiJPanHCYuMMohazebY, et al. 2019. Inactivation of Nell-1 in chondrocytes significantly impedes appendicular skeletogenesis. J Bone Miner Res. 34(3):533–546.
43.
QinXYZhaoHXZhangQChenFLinJX. 2016. Nell-1: a novel highly efficient and specific growth factor [in Chinese]. Beijing Da Xue Xue Bao Yi Xue Ban (Journal of Peking University Health Sciences). 48(2):380–383.
44.
RapaEHillSKMortenKJPotterMMitchellC. 2012. The over-expression of cell migratory genes in alveolar rhabdomyosarcoma could contribute to metastatic spread. Clin Exp Metastasis. 29(5):419–429.
45.
RudkowskaIGuenardFJulienPCouturePLemieuxSBarbierOCalderPCMinihaneAMVohlMC. 2014. Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation. J Lipid Res. 55(7):1245–1253.
46.
ShenJLaChaudGKhadarianKShresthaSZhangXSooCTingKDrySMJamesAW. 2015. NELL-1 expression in benign and malignant bone tumors. Biochem Biophys Res Commun. 460(2):368–374.
47.
ShenJLaChaudGShresthaSAsatrianGZhangXDrySMSooCTingKJamesAW. 2015. NELL-1 expression in tumors of cartilage. J Orthop. 12Suppl 2:S223–S229.
48.
SiuRKZaraJNHouYJamesAWKwakJZhangXTingKWuBMSooCLeeM. 2012. Nell-1 promotes cartilage regeneration in an in vivo rabbit model. Tissue Eng Part A. 18(3–4):252–261.
49.
SlovakMLBedellVHsuYHEstrineDBNowakNJDelioukinaMLWeissLMSmithDDFormanSJ. 2011. Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma. Clin Cancer Res. 17(10):3443–3454.
50.
TakahashiKImaiAIijimaMYoshimotoNMaturanaADKurodaSNiimiT. 2015. Mapping the heparin-binding site of the osteoinductive protein NELL1 by site-directed mutagenesis. FEBS Lett. 589(24 Pt B):4026–4032.
51.
TangRWangQDuJYangPWangX. 2013. Expression and localization of Nell-1 during murine molar development. J Mol Histol. 44(2):175–181.
52.
TanjayaJLordELWangCZhangYKimJKNguyenABaikLPanHCChenEKwakJH, et al. 2018. The effects of systemic therapy of PEGylated NEL-like protein 1 (NELL-1) on fracture healing in mice. Am J Pathol. 188(3):715–727.
53.
TanjayaJZhangYLeeSShiJChenEAngPZhangXTetradisSTingKWuB, et al. 2016. Efficacy of intraperitoneal administration of PEGylated NELL-1 for bone formation. BioRes Open Access. 5(1):159–170.
54.
ThamCChewMSoongRLimJAngMTangCZhaoYOngSYLiuY. 2014. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. Cancer. 120(20):3131–3141.
55.
TianHZhaoJBrochmannEJWangJCMurraySS. 2017. Bone morphogenetic protein-2 and tumor growth: diverse effects and possibilities for therapy. Cytokine Growth Factor Rev. 34:73–91.
56.
TingKVastardisHMullikenJBSooCTieuADoHKwongEBertolamiCNKawamotoHKurodaS, et al. 1999. Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res. 14(1):80–89.
57.
TombolanLPoliEMartiniPZinARomualdiCBisognoGLanfranchiG. 2017. NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma. Oncotarget. 8(20):33086–33099.
58.
WangBWuYYuHJiangLFangBGuoQ. 2018. The effects of NELL on corticotomy-assisted tooth movement and osteogenesis in a rat model. Biomed Mater Eng. 29(6):757–771.
59.
WangCHouWGuoXLiJHuTQiuMLiuSMoXLiuX. 2017. Two-phase electrospinning to incorporate growth factors loaded chitosan nanoparticles into electrospun fibrous scaffolds for bioactivity retention and cartilage regeneration. Mater Sci Eng C Mater Biol Appl. 79:507–515.
60.
WangZKambhampatiSChengYMaKSimsekCTieuAHAbrahamJMLiuXPrasathVDuncanM, et al. 2019. Methylation biomarker panel performance in esophacap cytology samples for diagnosing Barrett’s esophagus: a prospective validation study. Clin Cancer Res. 25(7):2127–2135.
61.
WuJWangQHanQZhuHLiMFangYWangX. 2019. Effects of Nel-like molecule-1 and bone morphogenetic protein 2 combination on rat pulp repair. J Mol Histol. 50(3):253–261.
62.
XiaLXuYChangQSunXZengDZhangWZhangXZhangZJiangX. 2011. Maxillary sinus floor elevation using BMP-2 and NELL-1 gene-modified bone marrow stromal cells and TCP in rabbits. Calcif Tissue Int. 89(1):53–64.
63.
XueJPengJYuanMWangAZhangLLiuSFanMWangYXuWTingK, et al. 2011. Nell1 promotes high-quality bone regeneration in rat femoral distraction osteogenesis model. Bone. 48(3):485–495.
64.
YamamotoNKashiwagiMIshiharaMKojimaTMaturanaADKurodaSNiimiT. 2019. Robo2 contains a cryptic binding site for neural EGFL-like (NELL) protein 1/2. J Biol Chem. 294(12):4693–4703.
65.
ZhaiYWeiRShaSLinCWangHJiangXLiuG. 2019. Effect of NELL1 on lung cancer stem-like cell differentiation. Oncol Rep. 41(3):1817–1826.
66.
ZhangJChenYXuJWangJLiCWangL. 2018. Tissue engineering using 3D printed nano-bioactive glass loaded with NELL1 gene for repairing alveolar bone defects. Regen Biomater. 5(4):213–220.
ZhangXKurodaSCarpenterDNishimuraISooCMoatsRIidaKWisnerEHuFYMiaoS, et al. 2002. Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest. 110(6):861–870.
69.
ZhangXPeaultBChenWLiWCorselliMJamesAWLeeMSiuRKShenPZhengZ, et al. 2011. The Nell-1 growth factor stimulates bone formation by purified human perivascular cells. Tissue Eng Part A. 17(19-20):2497–2509.
70.
ZhangXTingKPathmanathanDKoTChenWChenFLeeHJamesAWSiuRKShenJ, et al. 2012. Calvarial cleidocraniodysplasia-like defects with ENU-induced Nell-1 deficiency. J Craniofac Surg. 23(1):61–66.
71.
ZhangXZaraJSiuRKTingKSooC. 2010. The role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration. J Dent Res. 89(9):865–878.
72.
ZhaoHQinXZhangQZhangXLinJTingKChenF. 2018. Nell-1-ΔE, a novel transcript of Nell-1, inhibits cell migration by interacting with enolase-1. J Cell Biochem. 119(7):5725–5733.
73.
ZhuSSongDJiangXZhouHHuJ. 2011. Combined effects of recombinant human BMP-2 and NELL-1 on bone regeneration in rapid distraction osteogenesis of rabbit tibia. Injury. 42(12):1467–1473.
74.
ZhuSZhangBManCMaYHuJ. 2011. NEL-like molecule-1-modified bone marrow mesenchymal stem cells/poly lactic-co-glycolic acid composite improves repair of large osteochondral defects in mandibular condyle. Osteoarthritis Cartilage. 19(6):743–750.
75.
ZouXShenJChenFTingKZhengZPangSZaraJNAdamsJSSooCZhangX. 2011. NELL-1 binds to APRr3 affecting human osteoblast proliferation and differentiation. FEBS Lett. 585(15):2410–2418.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
